Begin your New Life in shape
3 Steps to weight-loss injection
Approved GLP-1 medications for weight loss in Switzerland
Wegovy®
Active ingredient semaglutide Injection once weekly
Mounjaro®
Active ingredient tirzepadite Injection once weekly
Ozempic® containing the active ingredient semaglutide is approved only for type 2 diabetes
Eligibility of GLP-1 medication for weight loss in Switzerland
BMI > 30
BMI ≥ 27 and < 30*
*With at least one weight-related comorbidity
Weight loss results from GLP-1 medication
Wegovy® ~15% of body weight (Step-1 study)
Mounjaro® ~15–21% of body weight (Surmount-1 study)
Dr. med Susanne Maurer the medical leader of NovaLife
Dr. med Susanne Maurer is a distinguished expert in obesity and metabolic medicine, with many years of clinical and scientific experience. After holding senior positions at renowned clinics in Germany and Switzerland, she now leads the Adimed Center for Obesity and Metabolic Medicine in Winterthur.
Begin Your New Life
In Shape
With NovaLife, you start your journey under medical supervision — guided by experienced specialists, proven treatments, and personalized care designed for lasting results.
Check Eligibility to Book Consultation
StartSecurely record your health profile and book appointments easily
Have a private video call with a doctor or licensed nurse
Receive your prescribed treatment directly and discreetly at home
seamless digital, video consultations
direct access and effective results
physician-led, evidence-based, safe
+ 40'000
Swiss use GLP-1
-15-21%
reduction of weight
Step-1 & Surmount-1 studies
2 GLP-1
approved medication
Wegovy®
Active ingredient semaglutide Injection once weekly
Mounjaro®
Active ingredient tirzepadite Injection once weekly
Ozempic® containing the active ingredient semaglutide is approved only for type 2 diabetes
BMI > 30
BMI ≥ 27 and < 30*
*With at least one weight-related comorbidity
Weight Loss Results
Wegovy® ~15% of body weight (Step-1 study)
Mounjaro® ~15–21% of body weight (Surmount-1 study)
Medical Expertise
Safe Effective Treatment - guided by doctors specialized in obesity and metabolic medicine
Dr. med Susanne Maurer is a distinguished expert in obesity and metabolic medicine, with many years of clinical and scientific experience. After holding senior positions at renowned clinics in Germany and Switzerland, she now leads the Adimed Center for Obesity and Metabolic Medicine in Winterthur.
Her work focuses on the holistic treatment of people living with obesity – always with the goal of achieving sustainable, healthy, and self-determined weight loss.
By combining profound expertise in internal medicine with deep knowledge of nutrition and exercise science, as well as extensive research and clinical practice, she is widely recognized as a leading voice in this field.
Here to make your experience as seamless as possible – explore answers to common questions about our services, policies and patient care.
GLP-1 medications such as Wegovy and Mounjaro can be powerful tools for weightloss. They help regulate appetite, improve blood sugar, and support healthier eating. But as with any strong medical therapy, safety and proper guidance are essential.With us, you get the best of both worlds: the power of GLP-1 treatment and the reassurance of expert medical care — delivered in a modern, flexible way.
Without supervision, taking GLP-1 drugs can be risky. Side effects like nausea or digestive issues may seem manageable, but more serious complications — such as low blood sugar, gallstones or kidney stress from dehydration — can develop silently and require expert attention. That’s why self-treatment without medical oversight is not safe.
We make monitoring as simple as possible: through telemedicine, secure digital communication, and flexible check-ins that fit your schedule. Our doctors adjust your dosage step by step, track your progress with lab work and safety checks, and provide practical guidance on nutrition and lifestyle.
-15% of body weight (Step-1 study)
CHF 375 / month
Monthly shipment of medication for 4 weeks of injections and adjucted dosage
Progress review via video consultation typically every 10 weeks
Access to experts in case of side effect issues
Excluding First Consultation
Self-pay only
-15-21% of body weight (Surmount-1 study)
CHF 590 / month
Monthly shipment of medication for 4 weeks of injections and adjucted dosage
Progress review via video consultation typically every 10 weeks
Access to experts in case of side effect issues
Excluding First Consultation
Self-pay only
With NovaLife, you start your journey under medical supervision — guided by experienced specialists, proven treatments, and personalized care designed for lasting results.
